A double-blind randomized controlled trial to assess the efficacy of Enbrel versus placebo in preventing relapses of chronic or recurrent uveitis

Purpose:To evaluate the efficacy of entanercept (Enbrel®) versus placebo in preventing relapses of chronic or recurrent non-infectious uveitis in patients controlled on and being tapered from methotrexate. Methods:20 patients with chronic or recurrent non-infectious uveitis, and with control of inflammation on low-dose (